Home » Topics » BioWorld Science

BioWorld Science
RSS

C&C Research presents several new series of compounds with antiestrogenic activity

Aug. 20, 2001

Merck & Co. describes novel derivatives as selective ligands for GABA-A receptors

Aug. 20, 2001

Compounds for the treatment of cellular protein transport disorders reported by Procter & Gamble

Aug. 20, 2001

Icos patents new potent and selective PDE4 inhibitors

Aug. 20, 2001

Roche designs new compounds for the treatment of type 2 diabetes

Aug. 20, 2001

SI-6601D found useful for local therapy in rheumatoid arthritis patients

Aug. 20, 2001

Flavonoid consumption associated with reduced incidence of COPD

Aug. 20, 2001

Phase I study successful for Prescient NeuroPharma's anhydrovinblastine

Aug. 20, 2001

Schering-Plough and Roche resolve peginterferon patent disputes

Aug. 20, 2001

Phase I trial initiated for Inspire's sinusitis therapy

Aug. 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.